Nobel Biocare Holdin (OTCMKTS:NBHGY) Stock Price, News, Analysis & History

$9.07 0.00 (0.00 %)
(As of 03/21/2018 04:00 PM ET)
Previous Close$9.07
Today's RangeN/A
52-Week Range$7.56 - $9.99
Average Volume10 shs
Market Capitalization$2.25 billion
P/E RatioN/A
Dividend YieldN/A

About Nobel Biocare Holdin (OTCMKTS:NBHGY)

Nobel Biocare Holdin logo.

Receive NBHGY News and Ratings via Email

Sign-up to receive the latest news and ratings for NBHGY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares247,570,000

Nobel Biocare Holdin (OTCMKTS:NBHGY) Frequently Asked Questions

What is Nobel Biocare Holdin's stock symbol?

Nobel Biocare Holdin trades on the OTCMKTS under the ticker symbol "NBHGY."

Who are some of Nobel Biocare Holdin's key competitors?

Has Nobel Biocare Holdin been receiving favorable news coverage?

Press coverage about NBHGY stock has been trending somewhat positive this week, Accern reports. Accern identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nobel Biocare Holdin earned a media sentiment score of 0.21 on Accern's scale. They also gave media coverage about the company an impact score of 46.46 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Nobel Biocare Holdin?

Shares of NBHGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nobel Biocare Holdin's stock price today?

One share of NBHGY stock can currently be purchased for approximately $9.07.

How big of a company is Nobel Biocare Holdin?

Nobel Biocare Holdin has a market capitalization of $2.25 billion.

MarketBeat Community Rating for Nobel Biocare Holdin (NBHGY)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about Nobel Biocare Holdin and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Nobel Biocare Holdin (OTCMKTS:NBHGY) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Earnings History for Nobel Biocare Holdin (OTCMKTS:NBHGY)

No earnings announcements for this company have been tracked by


Nobel Biocare Holdin (OTCMKTS:NBHGY) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Nobel Biocare Holdin (OTCMKTS:NBHGY)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Nobel Biocare Holdin (OTCMKTS NBHGY)

No insider trades for this company have been tracked by


Nobel Biocare Holdin (OTCMKTS NBHGY) News Headlines

No headlines for this company have been tracked by

SEC Filings

Nobel Biocare Holdin (OTCMKTS:NBHGY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Nobel Biocare Holdin (OTCMKTS NBHGY) Stock Chart for Wednesday, March, 21, 2018

Loading chart…

This page was last updated on 3/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.